ENTRY       D11397                      Drug
NAME        Darvadstrocel (INN);
            Alofisel (TN)
REMARK      ATC code: L04AX08
EFFICACY    Anti-inflammatory
  TYPE      Cellular therapy product
COMMENT     Treatment of complex perianal fistulas in adult patients with Crohn's disease (a disease causing inflammation of the gut)
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AX Other immunosuppressants
                 L04AX08 Darvadstrocel
                  D11397  Darvadstrocel (INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11397
             Cellular and gene therapy products
              D11397
            New drug approvals in Japan [br08318.html]
             Cellular and gene therapy products
              D11397
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11397
DBLINKS     PubChem: 384585375
///
